Jefferies Financial Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.07M Buy
32,000
+5,075
+19% +$358K 0.01% 632
2025
Q4
$1.81M Buy
+26,925
New +$1.81M 0.01% 851
2025
Q2
Sell
-12,263
Closed -$783K 1527
2025
Q1
$783K Buy
+12,263
New +$712K 0.01% 900
2024
Q1
Sell
-16,504
Closed -$610K 1777
2023
Q4
$610K Buy
+16,504
New +$622K ﹤0.01% 1139
2023
Q3
Sell
-44,250
Closed -$1.81M 1755
2023
Q2
$1.6M Buy
+44,250
New +$1.51M 0.01% 741

Other funds holding HALO

Jefferies Financial Group's HALO Position: Q1 2026 in Review

Jefferies Financial Group increased its Halozyme (HALO) stake by 19% in Q1 2026, buying an estimated $358K and bringing the position to 32,000 shares worth $2.07M. The position accounts for 0.01% of the portfolio, ranked #632.

Jefferies Financial Group first reported a position in HALO in Q2 2023 and has held it in 5 quarters since. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Jefferies Financial Group held 32,000 shares of Halozyme worth $2.07M as of Q1 2026.
  • Jefferies Financial Group bought 5,075 Halozyme shares in Q1 2026, an estimated $358K.
  • Halozyme made up 0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #632 holding.
  • Jefferies Financial Group first reported a position in Halozyme in Q2 2023 and has held it in 5 quarters since.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.